Mather Group’s Dare Bioscience DARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$177 Sell
84
-1
-1% -$2 ﹤0.01% 1867
2026
Q1
$155 Buy
+85
New +$145 ﹤0.01% 1856
2025
Q4
Sell
-84
Closed -$176 884
2025
Q3
$176 Buy
+84
New +$189 ﹤0.01% 1667
2025
Q2
Sell
-84
Closed -$243 875
2025
Q1
$243 Hold
84
﹤0.01% 1719
2024
Q4
$262 Hold
84
﹤0.01% 1687
2024
Q3
$272 Buy
84
+1
+1% +$3 ﹤0.01% 1644
2024
Q2
$490 Buy
+83
New +$402 ﹤0.01% 2074

Other funds holding DARE

Mather Group's DARE Position: Q2 2026 in Review

Mather Group reduced its Dare Bioscience (DARE) stake by 1.2% in Q2 2026, selling an estimated $2 and leaving 84 shares worth $177. The position accounts for ﹤0.01% of the portfolio, ranked #1867.

Mather Group first reported a position in DARE in Q2 2024 and has held it in 7 quarters since. The position peaked at $490 in Q2 2024. 6 funds tracked by Wall St. Rank hold DARE as of Q2 2026.

  • Mather Group held 84 shares of Dare Bioscience worth $177 as of Q2 2026.
  • Mather Group sold 1 Dare Bioscience share in Q2 2026, an estimated $2.
  • Dare Bioscience made up ﹤0.01% of Mather Group's portfolio in Q2 2026, its #1867 holding.
  • Mather Group first reported a position in Dare Bioscience in Q2 2024 and has held it in 7 quarters since.
  • Mather Group's Dare Bioscience position peaked at $490 in Q2 2024.
  • 6 funds tracked by Wall St. Rank held Dare Bioscience as of Q2 2026.

Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.